Revelation Biosciences, Inc.
REVB
$1.01
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -27.03% | 31.49% | 40.73% | 47.61% | 46.78% |
| Total Depreciation and Amortization | -2.08% | -5.90% | -2.87% | 5.19% | 10.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 323.00% | 143.88% | 453.78% | 4,654.69% | 506.11% |
| Change in Net Operating Assets | 100.18% | 105.47% | 99.83% | -106.07% | -238.86% |
| Cash from Operations | 47.35% | 52.46% | 54.86% | 39.37% | -96.08% |
| Capital Expenditure | -- | -- | -- | 147.97% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 147.97% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 46.25% | 158.55% | -2.61% | 76.86% | 99.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 45.56% | 158.00% | -2.93% | 76.86% | 99.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 191.45% | 195.96% | 176.49% | 182.75% | -89.63% |